Variant report
Variant | nsv581838 |
---|---|
Chromosome Location | chr2:50250758-50274774 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:22)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:22 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:50271154-50271446 | HepG2 | liver: | n/a | chr2:50271251-50271262 chr2:50271290-50271301 |
2 | EBF1 | chr2:50269267-50269547 | GM12878 | blood: | n/a | n/a |
3 | EBF1 | chr2:50274193-50274246 | GM12878 | blood: | n/a | n/a |
4 | EP300 | chr2:50266645-50266872 | SK-N-SH_RA | brain: | n/a | n/a |
5 | EP300 | chr2:50266622-50266833 | SK-N-SH_RA | brain: | n/a | n/a |
6 | EP300 | chr2:50266517-50267135 | SK-N-SH | brain: | n/a | chr2:50266883-50266891 |
7 | GATA2 | chr2:50266597-50266977 | SH-SY5Y | brain: | n/a | chr2:50266825-50266842 chr2:50266829-50266850 chr2:50266836-50266843 chr2:50266831-50266847 chr2:50266834-50266843 |
8 | GATA3 | chr2:50266677-50267063 | SH-SY5Y | brain: | n/a | chr2:50266825-50266842 chr2:50266829-50266850 chr2:50266836-50266843 chr2:50267013-50267025 chr2:50266831-50266847 chr2:50266834-50266843 |
9 | JUN | chr2:50264659-50264798 | K562 | blood: | n/a | n/a |
10 | MAFK | chr2:50262326-50262523 | HepG2 | liver: | n/a | chr2:50262375-50262386 |
11 | MYC | chr2:50257366-50257501 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | POLR2A | chr2:50259009-50259209 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | POLR2A | chr2:50258639-50258688 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr2:50260562-50260728 | ProgFib | skin: | n/a | n/a |
15 | POLR2A | chr2:50266455-50266521 | ProgFib | skin: | n/a | n/a |
16 | POLR2A | chr2:50268763-50268851 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | POLR2A | chr2:50273143-50273160 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | SPI1 | chr2:50270015-50270274 | HL-60 | blood: | n/a | n/a |
19 | STAT3 | chr2:50261176-50261287 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | USF1 | chr2:50263721-50263971 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | USF1 | chr2:50263698-50264018 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | ZNF143 | chr2:50269511-50269604 | GM12878 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NRXN1 | TF binding region |
ENSG00000179915 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17494917 | chr2:50250758-50250759 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs59497317 | chr2:50250763-50250764 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs538318627 | chr2:50250787-50250788 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs58018074 | chr2:50250823-50250824 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs565724777 | chr2:50250841-50250842 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs536592436 | chr2:50250857-50250858 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs554565918 | chr2:50250911-50250912 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs4971636 | chr2:50250919-50250920 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs185673122 | chr2:50250921-50250922 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs556567348 | chr2:50250957-50250958 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs149602785 | chr2:50250983-50250984 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs191563599 | chr2:50251007-50251008 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs184204918 | chr2:50251010-50251011 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs572454665 | chr2:50251048-50251049 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs187132256 | chr2:50251074-50251075 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs9677968 | chr2:50251100-50251101 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs561432019 | chr2:50251117-50251118 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs191137783 | chr2:50251133-50251134 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs549389191 | chr2:50251141-50251142 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs570888305 | chr2:50251158-50251159 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs182166848 | chr2:50251207-50251208 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs532111682 | chr2:50251217-50251218 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs187233701 | chr2:50251228-50251229 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs146126179 | chr2:50251232-50251233 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs545775941 | chr2:50251237-50251238 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs138998119 | chr2:50251297-50251298 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs6712956 | chr2:50251332-50251333 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs191647523 | chr2:50251356-50251357 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs6712970 | chr2:50251363-50251364 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs142274185 | chr2:50251421-50251422 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs578062035 | chr2:50251452-50251453 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs547028253 | chr2:50251515-50251516 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs562085100 | chr2:50251529-50251530 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs145935176 | chr2:50251532-50251533 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs553976531 | chr2:50251560-50251561 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs551101317 | chr2:50251593-50251594 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs148622053 | chr2:50251607-50251608 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs111932345 | chr2:50251613-50251614 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs561506942 | chr2:50251674-50251675 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs531910648 | chr2:50251690-50251691 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs543693277 | chr2:50251700-50251701 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs570949975 | chr2:50251750-50251751 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs78300745 | chr2:50251769-50251770 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs373580064 | chr2:50251774-50251775 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs564581432 | chr2:50251776-50251777 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs531981487 | chr2:50251795-50251796 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs547324887 | chr2:50251802-50251803 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs565649868 | chr2:50251806-50251807 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs368019740 | chr2:50251808-50251809 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs183051896 | chr2:50251856-50251857 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50250000-50250800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr2:50250400-50252200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr2:50250800-50252200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr2:50252200-50253800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr2:50252200-50254800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr2:50252400-50252600 | Enhancers | Fetal Heart | heart |
7 | chr2:50252600-50253600 | Enhancers | Primary hematopoietic stem cells | blood |
8 | chr2:50253000-50253400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr2:50253200-50253400 | Enhancers | Fetal Heart | heart |
10 | chr2:50253800-50256200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr2:50254800-50256600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr2:50256200-50257000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr2:50256600-50256800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr2:50259200-50265200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr2:50263800-50264200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
16 | chr2:50265200-50265800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr2:50265800-50269800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
18 | chr2:50266200-50266600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
19 | chr2:50266400-50267200 | Enhancers | Fetal Heart | heart |
20 | chr2:50268800-50269000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
21 | chr2:50269000-50270000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
22 | chr2:50269600-50270000 | Enhancers | Fetal Intestine Large | intestine |
23 | chr2:50269800-50270200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
24 | chr2:50270000-50271000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
25 | chr2:50270000-50271200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
26 | chr2:50270000-50271600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
27 | chr2:50270200-50270600 | Enhancers | Fetal Intestine Large | intestine |
28 | chr2:50270200-50270600 | Enhancers | Fetal Intestine Small | intestine |
29 | chr2:50270200-50271000 | Enhancers | Primary hematopoietic stem cells | blood |